AU7150991A - Aromatase inhibitors - Google Patents

Aromatase inhibitors

Info

Publication number
AU7150991A
AU7150991A AU71509/91A AU7150991A AU7150991A AU 7150991 A AU7150991 A AU 7150991A AU 71509/91 A AU71509/91 A AU 71509/91A AU 7150991 A AU7150991 A AU 7150991A AU 7150991 A AU7150991 A AU 7150991A
Authority
AU
Australia
Prior art keywords
aromatase inhibitors
aromatase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71509/91A
Other languages
English (en)
Inventor
Fernand Labrie
Yves Merand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endorecherche Inc
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Publication of AU7150991A publication Critical patent/AU7150991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU71509/91A 1990-02-08 1991-02-04 Aromatase inhibitors Abandoned AU7150991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US477024 1990-02-08
US07/477,024 US5227375A (en) 1990-02-08 1990-02-08 Aromatase inhibitors

Publications (1)

Publication Number Publication Date
AU7150991A true AU7150991A (en) 1991-09-03

Family

ID=23894189

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71509/91A Abandoned AU7150991A (en) 1990-02-08 1991-02-04 Aromatase inhibitors

Country Status (10)

Country Link
US (1) US5227375A (enExample)
AU (1) AU7150991A (enExample)
GR (1) GR910100067A (enExample)
IE (1) IE65269B1 (enExample)
IL (1) IL97122A (enExample)
MY (1) MY105479A (enExample)
NZ (1) NZ236966A (enExample)
TW (1) TW221418B (enExample)
WO (1) WO1991012206A2 (enExample)
ZA (1) ZA91604B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017489A1 (fr) * 1991-03-28 1992-10-15 Teikoku Hormone Mfg. Co., Ltd. Nouveau derive oxa- ou azasteroide
DE69324595T2 (de) * 1992-09-30 1999-08-19 Teikoku Hormone Mfg. Co. 7-substituierte oxa-steroid verbindung
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6117429A (en) * 1997-08-11 2000-09-12 Weider Nutrition International, Inc Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
MXPA00008868A (es) 1998-03-11 2003-04-25 Endorech Inc Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso.
EP1219631A4 (en) * 1999-08-23 2003-03-19 Chugai Pharmaceutical Co Ltd ANTIANDROGEN ACTIVE SUBSTANCES
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
TW200401781A (en) * 2002-03-22 2004-02-01 Pharmacia Corp C-17 spirolactonization and 6, 7 oxidation of steroids
RU2004131523A (ru) * 2002-03-22 2005-06-10 Фармация Корпорейшн (Us) С-17-спиролактонизация и 6,7-окисление стероидов
PL376896A1 (pl) * 2002-11-07 2006-01-09 Pharmacia & Upjohn Company Llc Sposoby wytwarzania 5-androstenów podstawionych w pozycji C-7
EP1709062B9 (en) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
BR112012029392A2 (pt) * 2010-05-20 2017-07-11 Univ Saskatchewan uso d einibidores de aromatase para a sincronização da ovulação, indução da superovulação ou ovulação dupla e melhora da geminação e fertilidade em um mamífero
US10004723B2 (en) 2013-04-19 2018-06-26 University Of Saskatchewan Aromatase inhibitor-releasing intravaginal device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125071C (enExample) * 1963-12-24
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
US3591607A (en) * 1966-04-19 1971-07-06 Hoffmann La Roche Retrosteroid a-ring formation
US3766213A (en) * 1966-04-19 1973-10-16 Hoffmann La Roche Retrosteroid a ring formation
US3485828A (en) * 1967-04-10 1969-12-23 Syntex Corp 6,7-ethylene and 6,7-substituted ethylene derivatives of the pregnane series
US3952018A (en) * 1972-01-14 1976-04-20 Hoffmann-La Roche Inc. 15-Oxasteroids
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
DE3121153A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
US4451404A (en) * 1983-02-09 1984-05-29 The Upjohn Company 16β-Methyl steroid process
US4596796A (en) * 1983-09-12 1986-06-24 Sumitomo Chemical Company, Limited Dithiolphosphoric acid ester as a soil pesticide
DE3612632A1 (de) * 1986-04-11 1987-10-22 Schering Ag Verfahren zur herstellung von 7(alpha)-propylsteroiden
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives

Also Published As

Publication number Publication date
WO1991012206A2 (en) 1991-08-22
ZA91604B (en) 1992-09-30
MY105479A (en) 1994-10-31
IL97122A (en) 1996-06-18
WO1991012206A3 (en) 1991-11-28
NZ236966A (en) 1993-11-25
TW221418B (enExample) 1994-03-01
US5227375A (en) 1993-07-13
IE910263A1 (en) 1991-08-14
IL97122A0 (en) 1992-05-25
IE65269B1 (en) 1995-10-18
GR910100067A (el) 1992-06-30

Similar Documents

Publication Publication Date Title
AU7683391A (en) Modified interleukin-1 inhibitors
GB9019558D0 (en) Enzyme inhibitors
AU660277B2 (en) 5-lipoxygenase inhibitors
AU1966292A (en) Substituted triazoles
AU5595194A (en) Custom-fitting articles
AU8582591A (en) Multifunctional scale inhibitors
AU4166393A (en) Auto-reclosers
AU3561193A (en) TNF-muteins
AU8292091A (en) Tnf inhibitors
AU7150991A (en) Aromatase inhibitors
AU8553891A (en) 1-(2-arylethyl)-pyrrolidines
AU3042892A (en) Rockbolt
AU4177593A (en) Benzophenonehydrazones
AU5161593A (en) Heterocyclic compound
AU3384593A (en) N-aryl-nitrogen heterocycles
AU4156393A (en) Heterocyclyltriazolinones
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU8769291A (en) Deoxyhypusyl hydroxylase inhibitors
AU4632493A (en) Weathershed
AU5118493A (en) Aromatase inhibitor
AU8694291A (en) Ester inhibitors
AU2402392A (en) New anti-diarrheic agents
AU3185693A (en) Pyrrolylbenzodiazepinones